bevacizumab,olaparib
Roche,Merck,Astrazeneca
['gyn', 'bevacizumab', 'vance', 'olaparib', 'ovarian']
olaparib plus bevacizumab maintenance therapy provides os benefit in advanced hrd-positive ovarian cancer #gyncsm #esmo2022 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.